BAKER Bros. Advisors L.P., Director, 10% Owner at IGM Biosciences, Inc. (IGMS), bought 788,330 shares at $8.26 ($6.8M) on 2024-03-26, disclosed to the SEC on 2024-03-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.26 | 247,656 | $2.0M | 30.0% |
| 2 | $8.26 | 22,344 | $185K | 2.7% |
| 3 | $8.26 | 22,344 | $185K | 2.7% |
| 4 | $8.26 | 247,656 | $2.0M | 30.0% |
| 5 | $9.22 | 17,101 | $158K | 2.3% |
| 6 | $9.22 | 17,101 |
| $158K |
| 2.3% |
| 7 | $9.22 | 1,543 | $14K | 0.2% |
| 8 | $9.27 | 8,439 | $78K | 1.1% |
| 9 | $9.27 | 761 | $7K | 0.1% |
| 10 | $9.27 | 8,439 | $78K | 1.1% |
| 11 | $9.62 | 8,066 | $78K | 1.1% |
| 12 | $9.62 | 8,066 | $78K | 1.1% |
| 13 | $9.62 | 89,407 | $860K | 12.6% |
| 14 | $9.62 | 89,407 | $860K | 12.6% |
| Total | $8.66 avg | 788,330 | $6.8M | 100% |
| Filing → |
| MDGL | BUY | 2023-12-14 | $45.0M | — | Filing → |
| TRDA | BUY | 2022-05-24 | $396K | — | Filing → |
| TRDA | BUY | 2022-05-18 | $631K | — | Filing → |